HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endod: safety evaluation of a plant molluscicide.

Abstract
Toxicity tests, in accordance with the Minimal Data Requirements (Tier 1) of the OECD Guidelines for Pre-Market Chemicals, were conducted on a standard extract (Endod-S) from the unripe berries of Phytolacca dodecandra, a potent botanical molluscicide of potential importance in the control of schistosomiasis. In acute mammalian toxicity tests, except for the eye irritation toxicity test which indicated severe irritancy, all test results were classified as either nontoxic or slightly toxic. Eye protection is therefore recommended during berry crushing and handling of dry powders. Ecotoxicity tests indicated that Endod is no more toxic than currently recommended synthetic molluscicides; however, environmental fate and additional local ecotoxicity tests are recommended for nontarget aquatic organisms present in the endemic situations of field trials. Given these toxicological data and recognizing the need for an affordable, locally cultivated, botanical molluscicide, it is concluded that field trials of Endod in schistosomiasis control are now justifiable.
AuthorsJ D Lambert, J H Temmink, J Marquis, R M Parkhurst, C B Lugt, E Lemmich, L Wolde-Yohannes, D de Savigny
JournalRegulatory toxicology and pharmacology : RTP (Regul Toxicol Pharmacol) Vol. 14 Issue 2 Pg. 189-201 (Oct 1991) ISSN: 0273-2300 [Print] Netherlands
PMID1792353 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Environmental Pollutants
  • Molluscacides
  • Phytolacca dodecandra extract
  • Plant Extracts
Topics
  • Animals
  • Environmental Pollutants
  • Female
  • Guinea Pigs
  • Lethal Dose 50
  • Male
  • Molluscacides (toxicity)
  • Mutagenicity Tests
  • Phytolacca dodecandra
  • Plant Extracts (chemistry, toxicity)
  • Rabbits
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: